No correlations were observed between NF-κB1–DNA binding and CGRP or TRPV1 gene expression, and between nuclear ReLA levels and each of CGRP, TAC1, or TRPV1 gene expression in DDD patients. This evidence concerns the gene TRPV1 and Dowling-Degos disease 1.